Literature DB >> 18071143

Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS.

M Hammad1, A Silva, J Glass, J T Sladky, M Benatar.   

Abstract

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a progressive degenerative disease of upper and lower motor neurons. Reports of the nature and frequency of sensory nerve involvement in ALS have varied.
METHODS: We reviewed the Emory University motor neuron disease registry between 1997 and 2004 to identify 103 patients with ALS without coexisting diseases that might cause sensory abnormalities and for whom electrodiagnostic studies were available for review. Neurophysiologic studies were interpreted based on age-adjusted normative data from our laboratory. Twelve control biopsies were evaluated alongside 22 samples from patients with ALS to ensure blinded evaluation of pathologic specimens.
RESULTS: Sensory symptoms or signs were present in 32% of patients, sural sensory nerve action potential amplitudes were abnormal in 27%, and pathologic abnormalities were present in 91% of patients. Large-caliber myelinated fibers were predominantly affected (reduced in 73%) and small-caliber myelinated fibers were affected less often (23%). Thinly myelinated fibers were present in 95% and regenerating clusters in 77% of the biopsies. Teased fiber analysis showed an increased frequency of axonal degeneration and regeneration as well as excessive myelin irregularity. Morphometry confirmed the loss of large-caliber fibers.
CONCLUSIONS: These data indicate that one third of patients with amyotrophic lateral sclerosis report sensory symptoms and sural sensory response amplitudes are reduced in a similar proportion of subjects. Pathologic evidence of sensory nerve pathology was present in 91% of patients who underwent sural nerve biopsy. The electrophysiologic and pathologic findings indicate a pattern of axonal loss that predominantly affects large-caliber myelinated fibers.

Entities:  

Mesh:

Year:  2007        PMID: 18071143     DOI: 10.1212/01.wnl.0000286948.99150.16

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  33 in total

Review 1.  ALS drug development: reflections from the past and a way forward.

Authors:  Swati Aggarwal; Merit Cudkowicz
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

Review 2.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

3.  Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study.

Authors:  A Pizzimenti; M Aragona; E Onesti; M Inghilleri
Journal:  Funct Neurol       Date:  2013 Apr-May

4.  Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship?

Authors:  Nadja Borisow; Thomas Meyer; Friedemann Paul
Journal:  BMJ Case Rep       Date:  2013-01-23

Review 5.  From animal models to human disease: a genetic approach for personalized medicine in ALS.

Authors:  Vincent Picher-Martel; Paul N Valdmanis; Peter V Gould; Jean-Pierre Julien; Nicolas Dupré
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

6.  An exploratory study of the association between thyroid hormone and survival of amyotrophic lateral sclerosis.

Authors:  Zhenzhen Zheng; Xiaoyan Guo; Rui Huang; Xueping Chen; Huifang Shang
Journal:  Neurol Sci       Date:  2014-02-07       Impact factor: 3.307

7.  Small-fibre neuropathy related to bulbar and spinal-onset in patients with ALS.

Authors:  A Truini; A Biasiotta; E Onesti; G Di Stefano; M Ceccanti; S La Cesa; A Pepe; C Giordano; G Cruccu; M Inghilleri
Journal:  J Neurol       Date:  2015-02-17       Impact factor: 4.849

8.  Sural nerve pathology in ALS patients: a single-centre experience.

Authors:  Marco Luigetti; Amelia Conte; Alessandra Del Grande; Giulia Bisogni; Angela Romano; Mario Sabatelli
Journal:  Neurol Sci       Date:  2011-12-28       Impact factor: 3.307

Review 9.  Molecular mechanisms underlying monosynaptic sensory-motor circuit development in the spinal cord.

Authors:  Fumiyasu Imai; Yutaka Yoshida
Journal:  Dev Dyn       Date:  2018-01-17       Impact factor: 3.780

Review 10.  Muscle wasting from kidney failure-a model for catabolic conditions.

Authors:  Xiaonan H Wang; William E Mitch
Journal:  Int J Biochem Cell Biol       Date:  2013-07-16       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.